CEO Mike Mahoney names Joe Fitzgerald EVP & COO at Boston Scientific as the medtech giant restructures into three clinical ...

Danaher CEO Julie Sawyer Montgomery described the planned AI lab as “an important milestone” towards expediting “the journey from discovery to impact” ...

CEO Brian Tyler will bring McKesson’s “experience and expertise” to support Option Care Health, following a US$5.8bn joint ...

Encouraging Phase 2 results show a robust immune response against serotype 3, prompting pivotal Phase 3 trials to protect up to 90% of paediatric patients Pfizer has announced the advancement of its ...

Mitie becomes a central partner at Macclesfield campus, one of AstraZeneca’s most significant global manufacturing and technology sites Innovation in healthcare is a long-standing necessity, and often ...

Dave Denton leaves Pfizer after overseeing major acquisitions and Cecile Guegan steps in as interim Chief Financial Officer while permanent search begins Pfizer has confirmed that Dave Denton, ...

From Oracle to Coupa and SAP to Blue Yonder, Healthcare Digital looks at the leading technological tools and companies ...

As payers, health systems and pharmaceutical giants compete to modernise patient experience, expedite drug development and keep pace with a rapidly evolving tech landscape, the Chief Digital Officer ...

This week’s top stories include GE HealthCare’s new AI Chief, BCG’s longevity market warning and Fresenius and NHS’ UK-first ...

Global research by Johnson & Johnson and Ipsos finds vision is overlooked as a menopause symptom, revealing a gap in ...

Iambic's technology is intended to complement the expertise of AbbVie's existing discovery teams rather than operate independently of them. Credit: AbbVie Nicholas Donoghoe, AbbVie’s Chief Business ...

Jonathon Lawrence, Managing Director UK&I at Fresenius, says the dialysis centre will put “lower-carbon design at the heart ...